Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1 Study to Evaluate the Efficacy and Safety Of AB-101, an Allogeneic Cord Blood Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III
Sponsored by Artiva Biotherapeutics, Inc
Active
$141.8K Funding
5 People
External
Related Topics
cell therapy,
immunotherapy,
cancer treatment,
clinical trial
People
Jazmin Dagnino
(CD)
College of Medicine - Tucson
﹒Clinical Research Coordinator III
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
C. Kent Kwoh
Principal Investigator (PI)
Medicine
﹒Professor
Gina Schwartzberg
(CD)
College of Medicine - Tucson
﹒Research Program Administration Manager II
